Analytics Legal analytics

24
March
2014

Commercial policies of pharmaceutical companies and medical device manufacturers: new lessons for market players

Federal Antimonopoly Service (FAS) and Russian court practice in addressing unreasonable refusals to enter into a supply agreement continues to develop. Several new cases considered by the FAS and the courts at the end of 2013/beginning of 2014 have enabled the identification of new trends in legal implementation policies.
We would like to offer you an analytical survey of VEGAS LEX on COMMERCIAL POLICIES OF PHARMACEUTICALS COMPANIES AND MEDICAL DEVICE: NEW LESSONS FOR MARKET PLAYERS.
In our latest issue:

Who is at risk?
How is market share determined?
What exactly may reveal a restraint on competition?
What to do next?

*The analytical survey of VEGAS LEX is an information periodical of law firm VEGAS LEX the main purpose of which is to inform the readers about the recent changers in legislation, court practice and other significant legal issues of business operation.

Related services

Related areas

VEGAS LEX_Коммерческие политики производителей лекарственных препаратов.Новые уроки для бинеса

Download file

File added	12.08.2015
Presentation	.pdf (398 Кб)

VEGAS LEX_Legal Alert_(eng)_4_03_2014